Segati R - Search Results

1

Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.

Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Among authors: segati r. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.

2

Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone.

Caffo O, Sava T, Comploj E, Giampaolo MA, Segati R, Valduga F, Cetto G, Galligioni E. Caffo O, et al. Among authors: segati r. Urol Oncol. 2010 Mar-Apr;28(2):152-6. doi: 10.1016/j.urolonc.2008.07.033. Epub 2008 Oct 10. Urol Oncol. 2010. PMID: 18848786 Clinical Trial.

3

Response and toxicity of cisplatin and 120-h 5-fluorouracil infusion in pretreated and untreated patients with advanced epidermoid cancer of the head and neck.

Paccagnella A, Pappagallo GL, Segati R, Zorat P, Cavaniglia G, Fosser VP, De Besi P, Fornasiero A, Fiorentino MV. Paccagnella A, et al. Among authors: segati r. Am J Clin Oncol. 1990 Jun;13(3):194-8. doi: 10.1097/00000421-199006000-00003. Am J Clin Oncol. 1990. PMID: 2346125

4

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.

Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, Sacco C, Veccia A, Galligioni E. Caffo O, et al. Among authors: segati r. BJU Int. 2011 Dec;108(11):1825-32. doi: 10.1111/j.1464-410X.2011.10277.x. Epub 2011 May 26. BJU Int. 2011. PMID: 21615854 Clinical Trial.

5

Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: results from a phase II study.

Caffo O, Fratino L, Barbieri R, Perin A, Martini T, Sava T, Segati R, Vaccher E, Bernardo Bassan F, Veccia A, Pappagallo G, Galligioni E. Caffo O, et al. Among authors: segati r. Urol Oncol. 2013 Feb;31(2):180-6. doi: 10.1016/j.urolonc.2010.11.012. Epub 2011 Jul 31. Urol Oncol. 2013. PMID: 21803618 Clinical Trial.

6

Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.

Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, Sacco C, Valduga F, Cetto G, Galligioni E. Caffo O, et al. Among authors: segati r. BJU Int. 2008 Nov;102(9):1080-5. doi: 10.1111/j.1464-410X.2008.07779.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485028 Clinical Trial.

7

Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.

Paccagnella A, Pappagallo GL, Segati R, Zorat P, Cavaniglia G, Lunghi F, Migliorini V, Frattina A, Bianco A, Sileni VC, et al. Paccagnella A, et al. Among authors: segati r. Eur J Cancer. 1993;29A(5):704-8. doi: 10.1016/s0959-8049(05)80350-8. Eur J Cancer. 1993. PMID: 7682427 Clinical Trial.

8

A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer.

Tomio L, Zorat PL, Paccagnella A, Segati R, Loreggian L, Lora O, Friso ML, Chiarion-Sileni V, Favaretto A, Fede A, et al. Tomio L, et al. Among authors: segati r. Am J Clin Oncol. 1993 Jun;16(3):264-7. doi: 10.1097/00000421-199306000-00014. Am J Clin Oncol. 1993. PMID: 8338061

9

Peptichemio in pretreated patients with plasmacell neoplasms.

Paccagnella A, Salvagno L, Chiarion-Sileni V, Bolzonella S, De Besi P, Frizzarin M, Pappagallo GL, Fosser VP, Fornasiero A, Segati R, et al. Paccagnella A, et al. Among authors: segati r. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1053-8. doi: 10.1016/0277-5379(86)90005-2. Eur J Cancer Clin Oncol. 1986. PMID: 3780812

10

Cis-dichlorodiammineplatinum (II), VP 16-213, and prednisone (DVP regimen) in the treatment of pretreated advanced malignant lymphomas.

Fosser VP, Salvagno L, Segati R, Pappagallo GL, Ferrazzi E, Sileni VC, Fiorentino MV. Fosser VP, et al. Among authors: segati r. Tumori. 1982 Dec 31;68(6):515-8. doi: 10.1177/030089168206800611. Tumori. 1982. PMID: 6762740 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page